In immunosuppressed people a simple at-home antibody test (as used in REACT-2) identified people with immunosuppression who remain most at risk after vaccination, providing a mechanism to further individualise protection approaches @imperialbrc.bsky.social https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02560-1/fulltext